Erratum: African descents are more sensitive than European descents to the antitumor compounds α-hederin and kalopanaxsaponin I (Planta Medica (2010) DOI: 10.1055/s-0030-1250061);African descents are more sensitive than European descents to the antitumor compoundsα-hederin and kalopanaxsaponin i

Planta Medica

Volumn 76, Issue 16, 2010, Pages 1847-1851

  Feller, Geva ^a   Kugel, Aleksandra ^a   Moonshine, Dana ^a   Chalifa Caspi, Vered ^a   Scholz, Martin ^b   Prüfer, Dirk ^b,c   Rabinski, Tatiana ^d   Müller, Kai J ^c   Ofir, Rivka ^a,d  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c FRAUNHOFER INSTITUTE FOR MOLECULAR BIOLOGY AND APPLIED ECOLOGY IME   (Germany)

^d The Dead Sea and Arava Science Center   (Israel)

Author keywords

HapMap; hederin; kalopanaxsaponin I; lymphoblastoid cell lines; Nigella sativa; Ranunculaceae; whole genome association

Indexed keywords

ALPHA HEDERIN; ANTINEOPLASTIC AGENT; KALOPANAXSAPONIN I; PACLITAXEL; SAPONIN DERIVATIVE; UNCLASSIFIED DRUG;

AFRICA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL GROWTH; CYTOTOXICITY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GROWTH INHIBITION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MAJOR CLINICAL STUDY; POPULATION; SINGLE NUCLEOTIDE POLYMORPHISM; WESTERN EUROPE;

NIGELLA SATIVA; RANUNCULACEAE;

EID: 78349253874     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1250325     Document Type: Erratum

References (33)

1. Ramadan M F. Nutritional value, functional properties and nutraceutical applications of black cumin (Nigella sativa L.): an overview. Int J Food Sci Technol 2007 42 1208-1218
2. Rooney S, Ryan M F. Effect of alpha-hederin and thymoquinone, constituents of Nigella sativa, on human cancer cell lines. Anticancer Res 2005 25 2199-2204
3. Ait Mbarek L, Ait Mouse H, Elabbadi N, Bensalah M, Gamouh A, Aboufatima R, Benharref A, Chait A, Kamal M, Dalal A, Zyad A. Anti-tumor properties of blackseed (Nigella sativa L.) extracts. Braz J Med Biol Res 2007 40 839-847
4. Kyung-Tae L, Sohn J C., Park H J., Kim D W., Jung G O., Park K T. Essential moiety for antimutagenic and cytotoxic activity of hederagenin monodesmosides and bisdesmosides isolated from the stem bark of Kalopanax pictus. Planta Med 2000 66 329-332
5. Kumara S S., Huat B T. Intracellular glutathione depletion and reactive oxygen species generation are important in -hederin-induced apoptosis of P388 cells. Mol Cell Biochem 2003 245 127-139
6. Kumara S S., Huat B T. Extraction, isolation and characterisation of antitumor principle, alpha-hederin, from the seeds of Nigella sativa. Planta Med 2001 67 29-32
7. Scholz M, Lipinski M, Leupold M, Luftmann H, Harig L, Ofir R, Fischer R, Prüfer D, Müller K J. Methyl jasmonate induced accumulation of kalopanaxsaponin I in Nigella sativa. Phytochemistry 2009 70 517-522
8. Tian Z, Liu Y M., Chen S B., Yang J S., Xiao P G., Wang L, Wu E. Cytotoxicity of two triterpenoids from Nigella glandulifera. Molecules 2006 11 693-699
9. Shukla S J., Duan S, Badner J A., Wu X, Dolan M E. Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosis. Pharmacogenet Genomics 2008 18 253-262
10. The International HapMap Consortium. A haplotype map of the human genome. Nature 2005 437 1299-1320
11. Meucci M A., Marsh S, Watters J W., McLeod H L. CEPH individuals are representative of the European American population: implications for pharmacogenetics. Pharmacogenomics 2005 6 59-63
12. Zhang W, Ratain M J., Dolan M E. The HapMap resource is providing new insights into ourselves and its application to pharmacogenomics. Bioinform Biol Insights 2008 2 15-23
13. Huang R S., Duan S, Shukla S J., Kistner E O., Clark T A., Chen T X., Schweitzer A C., Blume J E., Dolan M E. Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach. Am J Hum Genet 2007 81 427-437
14. Dudai N, Weinstein Y, Krup M, Rabinski T, Ofir R. Citral is a new inducer of caspase-3 in tumor cell lines. Planta Med 2005 71 484-488
15. O'Connell J R., Weeks D E. PedCheck: a program for identifying genotype incompatibilities in linkage analysis. Am J Hum Genet 1998 63 259-266
16. Abecasis G R., Cardon L R., Cookson W O. A general test of association for quantitative traits in nuclear families. Am J Hum Genet 2000 66 279-292
17. Huang R S., Duan S, Bleibel W K., Kistner E O., Zhang W, Clark T A., Chen T X., Schweitzer A C., Blume J E., Cox N J., Dolan M E. A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity. Proc Natl Acad Sci USA 2007 104 9758-9763
18. Huang R S., Duan S, Kistner E O., Bleibel W K., Delaney S M., Fackenthal D L., Das S, Dolan M E. Genetic variants contributing to daunorubicin-induced cytotoxicity. Cancer Res 2008 68 3161-3168
19. Iwakuma T, Tochigi Y, Van Pelt C S., Caldwell L C., Terzian T, Parant J M., Chau G P., Koch J G., Eischen C M., Lozano G. Mtbp haploinsufficiency in mice increases tumor metastasis. Oncogene 2008 27 1813-1820
20. Lange E M., Beebe-Dimmer J L., Ray A M., Zuhlke K A., Ellis J, Wang Y, Walters S, Cooney K A. Genome-wide linkage scan for prostate cancer susceptibility from the University of Michigan Prostate Cancer Genetics Project: suggestive evidence for linkage at 16q23. Prostate 2009 69 385-391
21. Yu K, Ganesan K, Tan L K., Laban M, Wu J, Zhao X D., Li H, Leung C H., Zhu Y, Wei C L., Hooi S C., Miller L, Tan P. A precisely regulated gene expression cassette potently modulates metastasis and survival in multiple solid cancers. PLoS Genet 2008 4 e1000129
22. Sinha S, Singh R K., Alam N, Roy A, Roychoudhury S, Panda C K. Alteration in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: pathological significance in early- and late-onset breast carcinoma. Mol Cancer 2008 7 84
23. Jiang H Y., Wek R C. Phosphorylation of the alpha-subunit of the eukaryotic initiation factor-2 (eIF2alpha) reduces protein synthesis and enhances apoptosis in response to proteasome inhibition. J Biol Chem 2005 280 14189-14202
24. Ljuslinder I, Golovleva I, Henriksson R, Grankvist K, Malmer B, Hedman H. Co-incidental increase in gene copy number of ERBB2 and LRIG1 in breast cancer. Breast Cancer Res 2009 11 403-404
25. Mulligan P, Westbrook T F., Ottinger M, Pavlova N, Chang B, Macia E, Shi Y J., Barretina J, Liu J, Howley P M., Elledge S J., Shi Y. CDYL bridges REST and histone methyltransferases for gene repression and suppression of cellular transformation. Mol Cell 2008 32 718-726
26. Bonne A, Vreede L, Kuiper R P., Bodmer D, Jansen C, Eleveld M, van Erp F, Arkesteijn G, Hoogerbrugge N, van Ravenswaaij C, Schoenmakers E F., Geurts van Kessel A. Mapping of constitutional translocation breakpoints in renal cell cancer patients: identification of KCNIP4 as a candidate gene. Cancer Genet Cytogenet 2007 179 8-11
27. Wu C H., Sahoo D, Arvanitis C, Bradon N, Dill D L., Felsher D W. Combined analysis of murine and human microarrays and ChIP analysis reveals genes associated with the ability of MYC to maintain tumorigenesis. PLoS Genet 2008 4 e1000090
28. Beuten J, Gelfond J A., Martinez-Fierro M L., Weldon K S., Crandall A C., Rojas-Martinez A, Thompson I M., Leach R J. Association of chromosome 8q variants with prostate cancer risk in Caucasian and Hispanic men. Carcinogenesis 2009 30 1372-1379
29. Huang X, Xiao D W., Xu L Y., Zhong H J., Liao L D., Xie Z F., Li E M. Prognostic significance of altered expression of SDC2 and CYR61 in esophageal squamous cell carcinoma. Oncol Rep 2009 21 1123-1129
30. Chen A A., Marsit C J., Christensen B C., Houseman E A., McClean M D., Smith J F., Bryan J T., Posner M R., Nelson H H., Kelsey K T. Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16 associated head and neck cancer. Carcinogenesis 2009 30 977-981
31. Malta-Vacas J, Chauvin C, Gonçalves L, Nazaré A, Carvalho C, Monteiro C, Bagrel D, Jean-Jean O, Brito M. eRF3a/GSPT1 12-GGC allele increases the susceptibility for breast cancer development. Oncol Rep 2009 21 1551-1558
32. Srsen V, Gnadt N, Dammermann A, Merdes A. Inhibition of centrosome protein assembly leads to p53-dependent exit from the cell cycle. J Cell Biol 2006 174 625-630
33. Park S K., Hwang Y S., Park K K., Park H J., Seo J Y., Chung W Y. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCd-mediated signaling in MCF-7 human breast cancer cells. Carcinogenesis 2009 30 1225-1233